Latest Articles
Advanced Endometrial Cancer Clinical Trial Pipeline - GlobeNewswire
Advanced Endometrial Cancer Clinical Trial Pipeline GlobeNewswire
Published: Sept. 3, 2026, 5 p.m.
ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study - TipRanks
ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study TipRanks
Published: Sept. 3, 2026, 4:55 p.m.
ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study - tipranks.com
ArriVent’s ARR-002 Moves Forward in Early Ovarian and Endometrial Cancer Study tipranks.com
Published: Sept. 3, 2026, 4:55 p.m.
When Common Health Conditions Tell A Bigger Story: The Hidden Link Between Endometrial Cancer And Metabolic Diseases - Health and Me
When Common Health Conditions Tell A Bigger Story: The Hidden Link Between Endometrial Cancer And Metabolic Diseases Health and Me
Published: Aug. 31, 2026, 7:30 a.m.
When Common Health Conditions Tell A Bigger Story: The Hidden Link Between Endometrial Cancer And Metabolic Diseases - healthandme.com
When Common Health Conditions Tell A Bigger Story: The Hidden Link Between Endometrial Cancer And Metabolic Diseases healthandme.com
Published: Aug. 31, 2026, 7:30 a.m.
NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk - inkl
NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk inkl
Published: Aug. 28, 2026, 2:45 a.m.
NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk - Medical Daily
NIH Backs Two USC Studies Asking Whether Forever Chemicals Contribute to Liver and Endometrial Cancer Risk Medical Daily
Published: Aug. 28, 2026, 2:40 a.m.
$7.5m NIH research to study how PFAS exposure contributes to liver and endometrial cancer - Innovation News Network
$7.5m NIH research to study how PFAS exposure contributes to liver and endometrial cancer Innovation News Network
Published: Aug. 27, 2026, 6:18 a.m.
Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer - CancerNetwork
Biomarker-Independent ADC Rina-S Advances to Phase 3 in Endometrial Cancer CancerNetwork
Published: Aug. 26, 2026, 8:08 p.m.
NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers - Keck School of Medicine of USC
NIH awards $7.5 million to study whether “forever chemicals” increase the risk of liver and endometrial cancers Keck School of Medicine of USC
Published: Aug. 26, 2026, 3:12 p.m.
Link copied to clipboard!